Role of cholecystokinin in the reduction of endomorphin-2-induced antinociception in diabetic mice.

[1]  J. Kamei,et al.  The role of spinal cholecystokinin B receptors in thermal allodynia and hyperalgesia in diabetic mice , 2001, Brain Research.

[2]  A. Eschalier,et al.  Potentiation of morphine and clomipramine analgesia by cholecystokinin -B antagonist CI-988 in diabetic rats , 2000, Neuroscience Letters.

[3]  M. Ohsawa,et al.  The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice. , 2000, European journal of pharmacology.

[4]  J. Crawley,et al.  International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. , 1999, Pharmacological reviews.

[5]  M. Ohsawa,et al.  Role of intracellular calcium in thermal allodynia and hyperalgesia in diabetic mice , 1999, Brain Research.

[6]  M. Ohsawa,et al.  Possible involvement of spinal protein kinase C in thermal allodynia and hyperalgesia in diabetic mice. , 1999, European journal of pharmacology.

[7]  M. Schwartz,et al.  Effect of Intracerebroventricular Insulin Infusion on Diabetic Hyperphagia and Hypothalamic Neuropeptide Gene Expression , 1995, Diabetes.

[8]  Xiao-jun Xu,et al.  Cholecystokinin and morphine analgesia: variations on a theme. , 1994, Trends in pharmacological sciences.

[9]  J. Kamei,et al.  Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic mice , 1992, Brain Research.

[10]  J. Kamei,et al.  Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonists , 1992, Brain Research.

[11]  Xiao-Jing Wang,et al.  Cholecystokinin octapeptide antagonized opioid analgesia mediated by μ- and κ- but not δ-receptors in the spinal cord of the rat , 1990, Brain Research.

[12]  L. Tseng,et al.  Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by beta-endorphin and morphine administered intracerebroventricularly in mice. , 1990, European journal of pharmacology.

[13]  S. Iversen,et al.  Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329 , 1989, Neuropharmacology.

[14]  B. Komisaruk,et al.  Morphine analgesia potentiated but tolerance not affected by active immunization against cholecystokinin. , 1984, Science.

[15]  M. Beinfeld.  Cholecystokinin in the central nervous system: A minireview , 1983, Neuropeptides.

[16]  L. Watkins,et al.  Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. , 1983, Science.

[17]  S. Itoh,et al.  Caerulein and cholecystokinin suppress β-endorphin-induced analgesia in the rat , 1982 .

[18]  J. Morley,et al.  Minireview. The ascent of cholecystokinin (CCK) - from gut to brain. , 1982, Life sciences.